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SUMMARY
p62/SQSTM1 (p62) is a scaffolding protein that facil-
itates the formation and degradation of ubiquitinated
aggregates via its self-interaction and ubiquitin bind-
ing domains. The regulation of this process is unclear
but may relate to the post-translational modification
of p62. In the present study, we find that Keap1/
Cullin3 ubiquitinates p62 at lysine 420 within its
UBA domain. Substitution of lysine 420 with an argi-
nine diminishes p62 sequestration and degradation
activity similar what is seen when the UBA domain
is deleted. Overexpression of Keap1/Cullin3 in p62-
WT-expressing cells increases ubiquitinated inclu-
sion formation and p62’s association with LC3 and
rescues proteotoxicity. This effect is not seen in cells
expressing a mutant p62 that fails to interact with
Keap1. Interestingly, p62 disease mutants have
diminished or absent UBA domain ubiquitination.
These data suggest that the ubiquitination of p62’s
UBA domain at lysine 420 may regulate p62’s func-
tion and be disrupted in p62-associated disease.
INTRODUCTION
Autophagic degradation can be a selective process targeting
distinct cargoes via autophagic receptor proteins (Rogov et al.,
2014). p62/SQSTM1 (p62) is an autophagic receptor that inter-
acts with ubiquitinated cargo via its ubiquitin association (UBA)
domain and recruits them via its LC3-interacting motif into the
growing autophagosome membrane (Bjørkøy et al., 2005;
Komatsu et al., 2007; Pankiv et al., 2007). Autophagic degrada-
tion of ubiquitinated proteins requires p62 to sequester them into
inclusion bodies. This property is mediated by p62’s UBA
domain but also via a PB1 domain that facilitates homo-oligo-
merization (Bjørkøy et al., 2005; Ciuffa et al., 2015; Itakura and
Mizushima, 2011).
The oligomerization of p62 may serve several different roles
in both inclusion body formation and autophagy. For example,
p62 oligomers may organize along with ubiquitinated proteins,
sequestering them into inclusions (Bjørkøy et al., 2005). In addi-
tion, p62 forms filamentous structures via its PB1 domain that
may serve as a site for phagophore membrane development
(Itakura and Mizushima, 2011). Interestingly, p62 filaments
are fragmented in the presence of polyubiquitin (Ciuffa et al.,
2015). This fragmentation is mediated via p62’s UBA domain
and suggests that higher-ordered oligomeric p62 structures
may dynamically change in the setting of ubiquitin.
Consistent with p62’s role in the handling of ubiquitinated
protein aggregates, dominantly inherited missense or deletion
mutations within p62’s UBA domain are associated with degen-
erative diseases, including Paget’s disease of the bone (PDB),
amyotrophic lateral sclerosis (ALS), fronto-temporal dementia,
and, more recently, inclusion body myopathy (Bucelli et al.,
2015; Rea et al., 2014). The common pathogenic feature among
these disparate tissues is the accumulation of p62 aggregates
and ubiquitinated inclusions. How p62 mutations contribute to
disease pathogenesis is unclear but may relate to diminished
ubiquitin binding activity (Layfield et al., 2006).
The post-translational modification of p62 has been demon-
strated to regulate its function. Phosphorylation at one of two
different serines within p62’s UBA domain enhances its associ-
ation with ubiquitinated proteins, promoting sequestering activ-
ity and rescue from proteotoxic stress (Lim et al., 2015; Matsu-
moto et al., 2011). Ubiquitination of p62 also occurs. Mass
spectrometry approaches have identified multiple ubiquitination
sites on p62 that include lysine residues within the PB1 and UBA
domains (Kim et al., 2011; Song et al., 2016).
Ubiquitination of p62 can also modulate its function. Recently,
studies identified ubiquitin ligases that, depending upon their site
of ubiquitination, inhibited or facilitated p62’s function (Heath
et al., 2016; Jongsma et al., 2016; Pan et al., 2016). The E3 ubiq-
uitin ligase TRIM21 ubiquitylates p62 at lysine 7 within its PB1
domain. This ubiquitination abrogates p62 oligomerization,
thus inhibiting p62’s sequestration activity (Pan et al., 2016).
p62 is also ubiquitinated within its UBA domain by the E3 ligase
RNF26, although the exact residue in the UBA domain was not
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determined. This ubiquitination event was proposed to enhance
p62’s interaction with other ubiquitin adaptors such as TOLLIP,
thus facilitating vesicular cargo sorting (Jongsma et al., 2016).
In addition, RNF166 ubiquitinates p62 at residues K91 and
K189 (Heath et al., 2016). Interestingly, these events involve
atypical ubiquitin chains that are K29- and K33-linked.
RNF166-mediated ubiquitin ligase activity facilitates p62’s role
in the xenophagic degradation of intracellular bacteria (Heath
et al., 2016).
p62 also associates with E3 ligases to regulate cell signaling
pathways. Keap1 is an E3 ligase adaptor that contains a BR-C,
ttk and bab (BTB) domain at its N terminus, whichmediates inter-
action with Cullin3 (Cul3) (Furukawa and Xiong, 2005). One sub-
strate of the Keap1/Cul3 complex is Nrf2. When Keap1 is desta-
bilized by oxidative stress, Nrf2 stabilizes and translocates to the
nucleus, where it activates the expression of genes regulated by
antioxidant response elements (Kobayashi et al., 2006). Several
studies demonstrate that p62 binds to Keap1, sequestering it
into aggregates under conditions of autophagic inhibition (Ichi-
mura et al., 2013; Komatsu et al., 2010; Lau et al., 2010). This
p62-Keap1 interaction titrates Keap1 away from Nrf2, stabilizing
Nrf2 by decreasing Cul3-mediated ubiquitination and allowing
Nrf2-mediated activation of the antioxidant response pathway.
In this study, we find that p62 is ubiquitinated at lysine 420
within its UBA domain. This ubiquitination is mediated by the
Keap1/Cul3 E3 ligase complex. Moreover, mutation of lysine
420 or disease mutations within p62’s UBA domain affect its
ubiquitination and diminish its sequestration activity. The ubiqui-
tination of ubiquitin binding proteins such as p62 is emerging as
an important regulatory mechanism for autophagic adaptor
proteins.
RESULTS
p62’s UBA Domain Is Ubiquitinated at K420
p62 associates with ubiquitinated proteins in cells (Bjørkøy et al.,
2005). We co-expressed HA-p62 and FLAG-ubiquitin (FLAG-Ub)
in p62/mouse embryonic fibroblasts (MEFs) for 24 hr and then
immunoprecipitated with a hemagglutinin (HA) antibody. Both
p62 and FLAG-Ub were detected within the immunoprecipitate
(Figure 1A). Interestingly, although FLAG-Ub migrated as a
high-molecular-weight (HMW) species in the cell lysate, it
migrated at 75 kDa in the HA immunoprecipitant (Figure 1A).
Moreover, an immunoblot of p62 from similar lysates demon-
strated both a 65-kDa band and several HMW species (Fig-
ure 1A). These data suggested that FLAG-Ub was conjugated
to p62. Treatment of cell lysates with the catalytic domain of
ubiquitin-specific protease 2 (Usp2cc) collapsed the HMW spe-
cies above p62 and abolished the presence of FLAG-Ub within
the HA immunoprecipitant (Figure 1A). N-ethylmaleimide (NEM)
increased the amount of ubiquitinated p62 and inhibited the
effect of Usp2cc (Figure 1A).
We co-expressed both FLAG-Ub and an HA-p62 construct
that lacks its UBA domain, p62-DUBA, and immunoprecipitated
with an antibody to HA in p62/MEFs. p62-DUBA failed to co-
immunoprecipitate any FLAG-Ub, even in the presence of NEM
(Figure 1B). A similar experiment was performed that co-ex-
pressed FLAG-Ub and an HA-p62 construct that lacks its N-ter-
minal PB1 domain, p62-DPB1. Similar to p62-DUBA, p62-DPB1
failed to co-immunoprecipitate any FLAG-Ub (Figure 1C). To see
whether this was related to a lack of a critical lysine residue such
as K7 or K13, which have been reported previously to be ubiqui-
tinated, or related to a lack of p62 dimerization, which is medi-
ated via the PB1 domain, we performed the same experiment
with HA-p62-D69A, which fails to dimerize but maintains all
N-terminal lysines (Figure 1D; Pan et al., 2016; Song et al.,
2016). Again, similar to p62-DPB1, no FLAG-Ub was immuno-
precipitated, suggesting that the dimerization of p62 may be
critical for the ubiquitination of p62’s C-terminal region.
To identify the principal lysine that is ubiquitinated on p62, we
selected seven sites determined by mass spectrometry analysis
and previous proteomic studies (Kim et al., 2011; Mertins et al.,
2013; Song et al., 2016; Wagner et al., 2011). We generated mul-
tiple HA-p62 mutant constructs with a lysine-to-arginine substi-
tution (K/R; Figure S1). Notably, the HA tag does not contain a
lysine. HA-p62 constructs were co-transfected with FLAG-Ub
into p62/ MEFs for 24 hr and then immunoprecipitated with
HA antibody in the presence of NEM. Mutation of all selected ly-
sines, HA-p62-7K/R, abolished the ubiquitination of p62, as seen
by the absence of FLAG-Ub in the immunoprecipitant (Figure 1E).
However, immunoprecipitation of p62 with mutations of six
lysine residues (HA-p62-6K/R), which retain the C-terminal
K420 residue, demonstrates FLAG-Ub in a pattern similar to
p62 wild-type (WT) (Figure 1E). Changing the lysine at amino
acid 420 to an arginine (HA-p62-K420R) diminished the amount
of FLAG-Ub in the immunoprecipitant, similar to HA-p62-DUBA
expression, suggesting that the principal ubiquitinated lysine
resides at K420 (Figure 1E).
To confirm that ubiquitin was indeed covalently attached
to p62, we co-transfected HA-p62-WT, HA-p62-K420R, or
p62-DUBA with histidine-tagged ubiquitin (His-Ub) into
p62/ MEFs for 24 hr and performed purification using a
Figure 1. p62 Is Ubiquitinated within Its UBA Domain
(A) Anti-p62 and anti-FLAG immunoblots of HA-immunoprecipitated lysates from p62/MEFs expressing HA-p62 and FLAG-Ub. Some lysates were incubated
with Usp2cc or NEM.
(B) Anti-p62 and anti-FLAG immunoblots of HA-immunoprecipitated lysates from p62/MEFs expressing HA-p62-WT or HA-p62-DUBA and FLAG-Ub. Some
lysates were treated with NEM.
(C) Anti-HA and anti-FLAG immunoblots of HA-immunoprecipitated lysates from p62/ MEFs expressing HA-p62-WT, HA-p62-DPB1, or HA-p62-DUBA and
FLAG-Ub.
(D) Anti-HA and anti-FLAG immunoblots of HA-immunoprecipitated lysates from p62/ MEFs expressing HA-p62-WT or HA-p62-D69A along with FLAG-Ub.
(E) Anti-HA and anti-FLAG immunoblots of HA-immunoprecipitated lysates fromp62/MEFs expressingHA-tagged p62-WT, p62-7K/R, p62-6K/R, p62-K420R,
or p62-DUBA and FLAG-Ub. Anti-GAPDH served as a loading control for the blots.
(F) Anti-HA immunoblots from p62/ MEFs expressing HA, HA-p62-WT, HA-p62-K420R, or HA-p62-DUBA and His-Ub. Anti-GAPDH served as a loading
control.
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nickel-charged affinity resin in the presence of 6M guanidine.
Consistent with our results in radioimmunoprecipitation assay
(RIPA) buffer, only HMW HA-p62-WT was present in the affin-
ity-purified lysate (Figure 1F).
p62’s UBA Domain Is Ubiquitinated by Keap1/Cul3
Because p62 interacts with Keap1, an adaptor for the E3
ligase Cul3, we expressed HA-p62-WT, HA-p62-K420R, and
HA-p62-DUBA with FLAG-Ub and Myc-Cul3 in p62/ MEFs
(Figure 2A; Komatsu et al., 2010). After 24 hr, immunoblotting
for p62 demonstrated an increase in ubiquitinated p62 in
Myc-Cul3-expressing cells, as evidenced by an increase in
HMW p62 bands that were not present in HA-p62-K420R- or
HA-p62-DUBA-expressing lysates (Figure 2A).
To further demonstrate that p62 could be ubiquitinated by
Cul3, we transfected p62/MEFs with an expression construct
containing a FLAG-tagged Cul3-WT or an inactive Cul3 that
lacks its C terminus (Cul3-DN) and immunoprecipitated Cul3
with an anti-FLAG antibody. Purified His-p62 lacking the first
84 amino acids of p62, which does not contain two previously re-
ported ubiquitination sites on p62 adjacent to the PB1 domain
(K7 or K13), was incubated with ubiquitin, immunoprecipitated
FLAG-Cul3, and recombinant E1/E2 enzymes. Consistent with
His-p62 ubiquitination, there was an increase in its molecular
weight when FLAG-Cul3-WT and not FLAG-Cul3-DN (dominant
negative) was included in the reaction (Figure 2B).
To function in ubiquitination reactions, Cul3 must be activated
by, and bound to, NEDD8 in a process called neddylation (Singer
et al., 1999). Cul3 activity can be inhibited using a nonspecific
neddylation inhibitor, MLN4924 (Soucy et al., 2009). Treatment
of p62/ MEFs expressing HA-p62 and FLAG-Ub with
MLN4924 and subsequent immunoprecipitation of HA-p62
A 
C 
B 
Figure 2. The Cul3 Complex Ubiquitinates p62
(A) Anti-p62 and anti-myc immunoblots of lysates from p62/ MEFs expressing HA-tagged p62-WT, p62-K420R or p62-DUBA, FLAG-Ub, and myc-Cul3.
(B) Anti-FLAG and anti-p62 immunoblot of recombinant p62 (DN84) following in vitro ubiquitination with immunoprecipitated FLAG-Cul3-WT or Cul3-DN from
p62/ MEFs.
(C) Anti-HA and anti-FLAG immunoblots of HA-immunoprecipitated lysates from p62/MEFs expressing HA-tagged p62-WT and FLAG-Ub. Some cells were
treated with MLN4924. Anti-GAPDH served as loading control for the blots.
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abolished p62 ubiquitination, as assessed by FLAG immunoblot
(Figure 2C).
Because p62 associates with Keap1, an adaptor of the Cul3
ligase complex, we reasoned that p62 ubiquitination may be
diminished in the absence of Keap1. We expressed HA-p62
and FLAG-Ub in Keap1/ MEFs with or without Myc-Keap1
for 24 hr and immunoprecipitated the lysates with an HA anti-
body. The amount of ubiquitinated p62 was increased when
Myc-Keap1 was expressed in Keap1/ MEFs (Figure 3A).
Immunoprecipitation of HA-p62 in p62/ MEFs expressing
FLAG-Ub, V5-Cul3, and Myc-Keap1 demonstrated more ubiqui-
tinated p62 compared with expression of HA-p62 and FLAG-Ub
alone (Figure 3B). This ubiquitination was abrogated when Myc-
Keap1-DBTB, which lacks its BTB domain, which is necessary
for Cul3 association, was expressed along with V5-Cul3, further
suggesting that the Keap1/Cul3 complex mediates ubiquitina-
tion of p62 (Figure 3B).
p62 binds to Keap1 via its Keap1-interacting region (KIR).
A single point mutation in p62, T350A, abolishes this interaction
(Komatsu et al., 2010). To further establish that p62 ubiquitina-
tion is facilitated via Keap1, we expressed HA-p62-WT,
HA-p62-T350A, or HA-p62-DUBA along with FLAG-Ub in
Keap1/MEFs with or without Myc-Keap1 for 24 hr and immu-
noprecipitated the lysates with an HA antibody. Although
Myc-Keap1 co-expression increased ubiquitinated HA-p62-
WT, as detected by FLAG antibody, there was no augmentation
of HA-p62-T350A when Myc-Keap1 was also expressed
(Figure 3C).
Because the previous studies used an overexpressed human
p62 construct in knockout mouse cells (see Figure S1B for the
level of overexpression compared with control lines), we wanted
to establish that endogenous p62 was indeed ubiquitinated. To
do this, we expressed His-Ub in U20S cells treated with vehicle
or MLN4924 for 24 hr and performed purification using a nickel-
charged affinity resin in the presence of 6M guanidine. Immuno-
blotting of the purified lysate with an antibody to p62 demon-
strated an HMW smear in His-Ub-transfected cells that was
reduced when MLN4924 was added to the cells (Figure 3D).
Similarly, we expressed Myc-Keap1 and V5-Cul3 in U20S cells
or treated these cells withMLN4924. Lysateswere then immuno-
blotted with a polyclonal antibody to p62. Myc-Keap1/V5-Cul3
co-expression increased the amount of a second bandmigrating
above p62, and this band disappeared with MLN4924 treatment
(Figure 3E).
UBA Domain Ubiquitination Enhances p62’s
Sequestering Activity
p62’s sequestering activity is required for ubiquitinated inclusion
body formation in the setting of autophagic impairment, and loss
of p62 leads to a reduction of insoluble ubiquitinated proteins
with a concomitant accumulation of soluble ubiquitinated
proteins (Komatsu et al., 2007). To explore this function, we
expressed a control vector, HA-p62-WT, HA-p62-K420R, and
HA-p62-DUBA in p62/MEFs and fractionated cell lysates via
ultracentrifugation (Figure 4A). In the absence of p62, ubiquiti-
nated proteins remain in the supernatant and do not shift to
the pelleted fraction. HA-p62-WT was enriched in the pelleted
fraction along with HMW ubiquitinated proteins. In contrast,
HA-p62-K420R and HA-p62-DUBA were enriched in the super-
natant fraction and did not shift ubiquitinated proteins to the
pelleted fraction.
Expression of HA-p62-WT in p62/MEFs generated multiple
punctate ubiquitin-positive inclusions throughout the cytoplasm.
In contrast, HA-p62-DUBA and HA-p62-K420R had markedly
fewer ubiquitin-positive inclusions (Figures 4B and 4C).
Co-expression of Myc-Keap1, V5-Cul3, or Myc-Keap1/V5-Cul3
increased the percentage of HA-p62-WT-expressing cells
containing ubiquitinated aggregates, which did not occur in cells
expressing HA-p62-K420R (Figure 4B; Figure S2). Similarly,
we expressed mCherry-p62-WT and mCherry-p62-K420R in
p62/ MEFs or ATG5/ MEFs and quantitated the average
size of p62 bodies. mCherry-p62-WT formed larger p62 bodies,
and this was greater in ATG5/ MEFs (Figures 4D and 4E). Co-
expression of Myc-Keap1/V5-Cul3 further increased mCherry-
p62-WT body size in both cell types, but mCherry-p62-WT body
size did not increase when Myc-Keap1-DBTB/V5-Cul3 were
co-expressed. In control fibroblasts, co-expression of Myc-
Keap1/V5-Cul3 increased mCherry-p62-WT body size, but this
augmentation didnot occurwithmCherry-p62-T350Aexpression
(Figure 4F). Co-expression of Myc-Keap1/V5-Cul3 increased the
size of endogenous p62 bodies, and MLN4924 treatment signifi-
cantly decreased the size in U20S cells (Figure S3).
mCherry-p62-WT or p62-K420R was expressed in p62/
MEFs, and live-cell imaging was performed to evaluate fluores-
cence recovery after photobleaching (FRAP) of individual puncta.
The initial rapid phase of recovery has been suggested to corre-
latewith p62’s sequestering activity (Matsumoto et al., 2011). The
fluorescence exchange rate of mCherry-p62-K420R was more
rapid than that of mCherry-p62-WT, and co-expression of
Myc-Keap1/V5-Cul3 decreased fluorescence recovery, whereas
co-expression of Myc-Keap1-DBTB/V5-Cul3 increased fluores-
cence recovery (Figures 5A and 5B). In a similar experiment,
co-expression of Myc-Keap1/V5-Cul3 failed to decrease the
fluorescence recovery of mCherry-p62-T350A (Figure 5C). The
differences in fluorescent recovery were not due to p62 presence
within an autophagosome because an experiment performed in
ATG5/MEFs gave similar results (Figures S4A and S4B).
UBA Domain Ubiquitination Increases p62 Degradation
We reasoned that the increased p62 exchange rate seen
with mCherry-p62-K420R compared with mCherry-p62-WT
may reduce phagophore association with p62. To test this, we
expressed HA-p62-WT or HA-p62-K420R with FLAG-Ub in
p62/ MEFs for 24 hr. Cell lysates were immunoprecipitated
with an anti-HA antibody and immunoblotted for HA and LC3B.
HA-p62-K420R immunoprecipitants had less LC3BII compared
with HA-p62-WT (Figure 6A). Consistent with this, cell lysates
immunoprecipitated with anti-HA from p62/ MEFs ex-
pressing HA-p62-WT with FLAG-Ub, Myc-Keap1, and V5-Cul3
in p62/ MEFs had an increase in LC3BII association, as
observed on immunoblots probed with HA and LC3 (Fig-
ure 6B). Similarly, although Myc-Keap1/V5-Cul3 co-expression
increased HA-p62-WT association with LC3B, this was not
seen for HA-p62-T350A (Figure 3C).
To further explore the role of UBA domain ubiquitination
by Keap1/Cul3 on p62’s degradation, we expressed
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Figure 3. Keap1 Modulates p62 Ubiquitination
(A) Anti-HA and anti-FLAG immunoblots of HA-immunoprecipitated lysates from Keap1/ MEFs expressing HA-p62-WT, FLAG-Ub, and myc-Keap1.
(B) Anti-HA and anti-FLAG immunoblots of HA-immunoprecipitated lysates from p62/ MEFs expressing HA-p62, FLAG-Ub, V5-cul3, and myc-Keap1-WT or
myc-Keap1-DBTB.
(C) Anti-HA, anti-FLAG, and LC3 immunoblots of HA-immunoprecipitated lysates from Keap1/ MEFs expressing FLAG-Ub, HA-p62-WT, HA-p62-T350A, or
HA-p62-DUBA with or without myc-Keap1.
(D) Anti-p62 immunoblot of nickel resin-purified lysates from U20S cells expressing His-Ub and treated with DMSO or MLN4924.
(E) Anti-p62 immunoblot of lysates from U20S cells with or without Myc-Keap1/V5-Cul3 expression or treated with MLN4924. Anti-GAPDH served as a loading
control for the blots.
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Figure 4. Keap1/Cul3-Mediated Ubiquitination of p62 Increases Sequestering Activity
(A) Anti-HA and anti-ubiquitin immunoblots of cellular lysates (10%of total, supernatant, and pellet) from p62/MEFs expressing empty HA vector, HA-p62-WT,
HA-p62-K420R, or HA-p62-DUBA.
(legend continued on next page)
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tandem-tagged mCherry-GFP-p62-WT in p62/MEFs for 24 hr
with and without Bafilomycin A (BafA) (Figure 6C). When
mCherry-GFP-p62-WT is in the cytosol as an inclusion body or
within the non-acidic environment of an autophagosome, both
mCherry and GFP fluorescence are present (Pankiv et al.,
2007). However, when mCherry-GFP-p62-WT enters an acidic
environment such as an autolysosome, GFP fluorescence
quenches, leaving only mCherry fluorescence. Consistent with
this, the degree of mCherry:GFP co-localization was increased
in BafA-treated cells compared with untreated cells (Figure 6C;
Figures S5A and S5B). In addition, co-expression of Myc-
Keap1/V5-Cul3 with mCherry-GFP-p62-WT decreased the
degree of mCherry:GFP co-localization, suggesting that p62
ubiquitination enhances its autophagic degradation (Figure 6C).
This effect was not seen in the presence of BafA.
The ratio of mCherry:GFP co-localization in p62/ MEFs
expressing mCherry-GFP-p62-K420R or mCherry-GFP-p62-
T350A was significantly increased compared with mCherry-
GFP-p62-WT, suggesting that fewer p62-K420R or p62-T350A
puncta were within autolysosomes (Figure 6C). In contrast to
mCherry-GFP-p62-WT puncta, there was no decrease in
mCherry:GFP co-localization with Myc-Keap1/V5-Cul3 expres-
sion in mCherry-GFP-p62-K420R- or mCherry-GFP-p62-
T350A-expressing p62/ MEFs (Figure 6C).
We reasoned that the increase inmCherry:GFP co-localization
in p62/ MEFs expressing mCherry-GFP-p62-K420R or
mCherry-GFP-p62-T350Awas due to its cytoplasmic accumula-
tion in inclusion bodies rather than accumulation within autopha-
gosomes. Consistent with this, p62/ MEFs expressing
mCherry-p62-K420R or mCherry-p62-T350A had a reduction
in co-localization with co-expressed GFP-LC3B compared
with mCherry-p62-WT-expressing p62/ MEFs (Figure 6D).
Moreover, expression of Myc-Keap1/V5-Cul3 increased the
GFP-LC3B or endogenous LC3B co-localization with mCherry-
p62-WT but failed to do so in mCherry-p62-K420R- or
mCherry-p62-T350A-expressing p62/ MEFs (Figure 6D;
Figure S5C).
Further studies demonstrated that the stability of endogenous
p62 was increased in Keap1/ MEFs compared with control
MEFs when cell lysates were immunoblotted for p62 from cells
treated with cycloheximide for varying times (Figure 6E). This
increase in p62 stability was abrogated in Keap1/ MEFs
that were transfected with Myc-Keap1/V5-Cul3 expression
constructs.
The expression of HttQ72-CFP in p62/ MEFs is toxic, with
only 5% of transfected cells remaining viable 24 hr after trans-
fection (Figure 6F). This toxicity is rescued when HA-p62-WT is
expressed but not by HA-p62-K420R, HA-p62-DUBA, or
HA-p62-T350A (Figure 6F). The expression ofMyc-Keap1 and/or
V5-Cul3 without HA-p62-WT in p62/MEFs did not significantly
change HttQ72-CFP toxicity. However, co-expression of Myc-
Keap1/V5-Cul3 along with HA-p62-WT enhanced cell viability.
This effect was not seen in the setting of HA-p62-K420R,
HA-p62-DUBA, or HA-p62-T350A (Figure 6F).
UBA Domain Ubiquitination in p62 Is Diminished with
Disease Mutations
Some p62 disease mutations reside within its UBA domain
(Figure 1C; Rea et al., 2014). We expressed HA-p62-WT,
p62-K420R, and five different disease mutations, p62-A390X
(equivalent to p62-DUBA used above), p62-P392L,
p62-M404V, p62-G411S, and p62-G425R along with FLAG-Ub
in p62/MEFs (Figure 7A). After 24 hr, we immunoprecipitated
cell lysates with an HA antibody and immunoblotted for FLAG
and HA. Immunoprecipitants from HA-p62-WT, but not
HA-p62-K420R or HA-p62-A390X, had FLAG-immunoreactive
bands (Figure 7A). In addition, all expressed p62 disease mu-
tants showed an absence or reduction in FLAG immunoreactivity
(Figure 7A). FRAP analysis of mCherry-p62-WT, p62-P392L,
p62-M404V, p62-G411S, or p62-G425R in p62/MEFs demon-
strated that fluorescence recovery was more rapid with all dis-
ease mutants compared with mCherry-p62-WT (Figure 7B;
Figure S6). HA-p62-WT increased the number of live cells ex-
pressing HttQ72-CFP, and this was augmented with co-expres-
sion of Keap1/Cul3 in p62/ MEFs (Figure 7C). Expression of
p62 disease mutants, with the exception of HA-p62-P392L,
significantly decreased cell viability compared with HA-p62-
WT. Co-expression of Keap1/Cul3 in p62 disease mutant-
expressing cells reduced cell death.
DISCUSSION
The present study finds that p62 is ubiquitinated at a highly
conserved lysine within its UBA domain (K420) by Keap1/Cul3.
Substitution of K420 to arginine, deletion of the UBA domain,
or mutation of the KIR domain in p62 decreases ubiquitinated
inclusion formation, its LC3 interaction, and cell viability. In
contrast, Keap1/Cul3 expression can increase ubiquitinated
inclusion formation and p62 inclusion body size and rescue cells
from proteotoxic stress. Moreover, Keap1/Cul3 increases p62’s
association with LC3B and its subsequent degradation. We
propose that the ubiquitination of p62’s UBA domain by
Keap1/Cul3 enhances its sequestration activity, subsequent
phagophore association, and degradation.
The molecular assembly of p62 oligomers is necessary for its
function in autophagy. How this assembly is regulated is not fully
understood. Recent studies support a model where the self-as-
sociation of p62 occurs via its PB1 domain (Ciuffa et al., 2015).
(B) Quantitation of p62/ MEFs expressing HA-p62-WT, HA-p62-K420R, or HA-p62-DUBA or co-transfected with myc-Keap1 and myc-Keap1/V5-cul3
containing ubiquitinated inclusions. Representative data were pooled from four independent experiments. All data are represented as mean ± SEM. *p < 0.05.
(C) Anti-Ub immunostaining of p62/ MEFs expressing empty vector, HA-p62-WT, K420R, or DUBA. Scale bars, 1 mm.
(D) Quantitation of p62 body size in p62/ and ATG5/ MEFs expressing mCherry-tagged p62-WT or p62-K420R with myc-Keap1, myc-Keap1-DBTB, and
V5-Cul3. All data are represented as mean ± SEM. *p < 0.05.
(E) Representative images of ATG5/ MEFs expressing Cherry-p62-WT or K420R along with Myc-Keap1/V5-Cul3. Scale bars, 1 mm.
(F) Quantitation of p62 body size in MEFs expressing mCherry-tagged p62-WT or p62-T350A with or without myc-Keap1/V5-cul3. All data are represented as
mean ± SEM. *p < 0.05.
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This interaction is a nidus for the extension of a filamentous p62
scaffold that allows the engulfing phagophore membrane to bind
the LC3 interacting region (LIR) domain and degrade ubiquiti-
nated proteins (Itakura and Mizushima, 2011). Deletion of the
PB1 domain abrogates the self-association of p62, reducing
p62’s sequestration activity and cellular function (Bjørkøy et al.,
2005). Similarly, deletion of p62’s UBA domain impairs p62
body formation even in the setting of an intact PB1 domain.
p62’s UBA domain can also self-associate as a dimer (Long
et al., 2010). Phosphorylation of serines 403 and 409 within the
UBA domain destabilizes this dimer and regulates p62’s activity
(Lim et al., 2015; Matsumoto et al., 2011). These studies suggest
that p62’s molecular assembly is dependent upon both its
PB1 and UBA domains.
The UBA domain of p62 has a shared interface that mediates
dimerization and ubiquitin binding. Ubiquitin binding and UBA
domain dimerization are mutually exclusive, with dimerization
‘‘inactivating’’ ubiquitin binding (Long et al., 2010). Amino acid
K420 resides at the C terminus of helix 2. Structural studies
have demonstrated that this region of p62’s UBA domain inter-
actswith residues in loop 1. Indeed, pointmutations in loop 1 res-
idues (E409K and G410K) or helix 2 (T419K) disrupt dimerization
(Long et al., 2010). Whether ubiquitination of K420 disrupts
dimerization, allowing increased ubiquitin binding, is unclear.
Alternatively, K420 ubiquitination may serve as a means for
increased oligomer formation via interaction of a p62 UBA
domain with an adjacent p62 ubiquitinated UBA domain or inter-
actions with other proteins harboring ubiquitin-binding motifs.
More recently, it was demonstrated that polyubiquitin could
fragment p62 filaments, suggesting that the oligomeric structure
of p62 was dynamic and could change with the addition of ubiq-
uitinated cargo (Ciuffa et al., 2015). Our data extend this model
and suggest that the ubiquitination status of p62’s UBA domain
may alter p62’s oligomeric structure, thus promoting inclusion
body formation. This higher-ordered p62 oligomer would then
further promote p62’s sequestration activity, subsequent phag-
ophore assembly, and autophagic degradation. We suggest
that, by refining p62’s oligomeric structure via UBA domain ubiq-
uitination, autophagic degradation and sequestration activity
can be activated or inhibited locally within the p62 inclusion
body.
The ubiquitination of autophagic adaptors is emerging as a
means of regulating their function. Ubiquitination of optineurin
by HACE1 increases its association with p62, enhancing auto-
phagic flux and suppressing tumor growth (Liu et al., 2014).
TRIM21 ubiquitinates p62 on its N-terminal PB1 domain, inhibit-
ing p62 oligomerization and sequestration activity (Pan et al.,
2016). This event would antagonize Keap1/Cul3-mediated ubiq-
uitination at the C-terminal UBA domain, suggesting that the
ubiquitination of p62 can both positively and negatively affect
its sequestration function. Recently, the E3 ligase RPN26 was
found to recruit and ubiquitinate p62’s UBA domain at the endo-
plasmic reticulum (ER) membrane (Jongsma et al., 2016). This
event enhanced p62’s ability to capture a subset of endosomes
via binding to ubiquitin binding domains on endocytic adaptors.
It has not been established whether RPN26 ubiquitinates K420
or another lysine within the UBA.
Previous studies have found that a Keap1 homodimer binds to
two sites on Nrf2, facilitating Cul3-mediated ubiquitination.
Oxidative stress destabilizes Keap1 and abrogates it interac-
tions with Nrf2. Keap1 binds p62 at a single KIR domain. The af-
finity for this interaction becomes greater as p62 accumulates
under conditions of impaired autophagy, sequestering Keap1
from Nrf2, leading to its stabilization (Jain et al., 2010; Komatsu
et al., 2010; Lau et al., 2010). Similarly, Keap1 accumulates un-
der conditions of impaired autophagy or in the setting of p62
knockdown (Lau et al., 2013). Autophagic degradation of
Keap1 through its interaction with p62 may help to maintain
redox homeostasis (Watanabe et al., 2012). In fact, Keap1 itself
enhances p62-mediated ubiquitin aggregate clearance (Fan
et al., 2010). This may further serve to regulate Keap1 levels
and its interactions with both Nrf2 and p62.
Our data suggest that Keap1/Cul3 can ubiquitinate p62 and
enhance its autophagic activity. Only dimeric p62 is able to be
ubiquitinated because p62 with a PB1 domain deletion and
p62-D69A fail to be ubiquitinated (Figures 1C and 1D). This
would suggest that a Keap1 homodimer binds to two high-affin-
ity KIR motifs on a p62 dimer, leading to its ubiquitination. This
model is similar to alternative models of Keap1, which suggests
that a homodimer can associate with two Nrf2 molecules or with
Nrf2 and a second protein with a KIR motif, such as PGAM5,
which then targets this complex to the mitochondria (Lo and
Hannink, 2006; Lo et al., 2006). Interestingly, loss of Keap1 sta-
bilizes p62, whereas increased expression of Keap1/Cul3 in-
creases p62 inclusion formation and subsequent degradation.
Whether Keap1 is further degraded along with p62 is not known.
However, Keap1/Cul3-mediated ubiquitination and subsequent
enhancement of p62 degradation would be an efficient means
by which Keap1 could decrease the levels of p62, thus releasing
its antagonistic interaction.
Dominantly inherited mutations in p62 are associated with
several degenerative diseases ranging from PDB to ALS (Rea
et al., 2014). More recently, homozygous loss-of-function muta-
tions in p62 were identified in patients with childhood-onset neu-
rodegeneration (Haack et al., 2016). Some p62 disease muta-
tions reside within or lead to premature truncations of the UBA
domain (Rea et al., 2014). One unifying feature for these muta-
tions is variable degrees of impaired ubiquitin binding in vitro
(Layfield et al., 2006). Our data find that UBA domain-associated
p62 disease mutations also have a reduction in UBA domain
Figure 5. p62 Ubiquitination Modulates Its Exchange Rate
(A) The average relative fluorescent intensity (RFI) following photobleaching from p62/ MEFs expressing mCherry-p62-WT or p62-K420R and V5-Cul3 with
myc-Keap1-WT or myc-Keap1-DBTB. Representative data were pooled from four independent experiments.
(B) Representative live-cell images of mCherry-p62-WT or p62-K420R and V5-cul3 with myc-Keap1-WT or myc-Keap1-DBTB following photobleaching and
fluorescence recovery. The circle indicates the photobleached area. Scale bars, 1 mm.
(C) The average RFI following photobleaching from p62/MEFs expressing mCherry-p62-WT or p62-T350A and V5-Cul3 with myc-Keap1-WT. Representative
data were pooled from three independent experiments.
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ubiquitination. More recently, several p62 missense mutations
associated with PDB and ALS have been identified within the
Keap1-interacting region (Goode et al., 2016b; Wright et al.,
2013). These mutations lead to a loss of Keap1 interaction and
a reduction in Nrf2 signaling. It is intriguing to speculate that
these mutations may also affect Keap1/Cul3-associated ubiqui-
tination of p62’s UBA domain, further unifying the pathogenic
mechanism of p62 mutations. Alternatively, xenophagy-associ-
ated phosphorylation of p62 at serine 349 can be disrupted by
a point mutation within the UBA domain that diminishes its ubiq-
uitin binding function (Ishimura et al., 2014). The phosphorylation
of serine 349 on p62 then increases p62’s affinity for Keap1
(Ichimura et al., 2013). It is also conceivable that UBA domain-
associated disease mutations in p62 affect serine 349 phos-
phorylation, abrogating Keap1/Cul3-mediated ubiquitination of
the UBA domain.
The modulation of p62 activity via Keap1/Cul3 is an attractive
therapeutic target. Expression of Keap1/Cul3 increases p62’s
sequestration activity. In the case of p62-associated disease
mutations, Keap1/Cul3 expression restored p62’s cytoprotec-
tive role in polyglutamine toxicity. Whether Keap1/Cul3-medi-
ated ubiquitination of p62 further enhances the sequestration
of Keap1, resulting in the non-canonical activation of Nrf2, which
may further enhance cell viability, remains to be established.
Indeed, activation of Nrf2 is cytoprotective in models of polyglut-
amine toxicity (Gan and Johnson, 2014). Our present data further
connect p62-mediated autophagy with the Keap1-Nrf2 signaling
pathway.
EXPERIMENTAL PROCEDURES
Immunoprecipitation and Western Blotting
Cells were harvested in NP-40 lysis buffer (50 mM Tris [pH 7.7], 150 mM NaCl,
and 1% NP-40) or RIPA buffer (50 mM Tris [pH 7.7], 150 mM NaCl, 1% NP-40,
0.5% sodium deoxycholate, and 0.1% SDS) with protease inhibitor cocktails
(PICs) (Sigma, #P8340), 20 mMNEM, and PMSF (Sigma, #P7626) and washed
with ice-chilled PBS. Lysates were centrifuged for 15 min at 4C and
16,000 3 g. The supernatants were collected. Some lysates were incubated
with Usp2cc (1 mg Usp2cc per 100 mg cell lysates; R&D Systems, #O75604).
200 mg of cell lysates were pre-cleared for 1 hr with end-over-end rotation
with 10 mg of Dynabeads M-270 epoxy (Life Technologies, #14302D) at 4C.
Samples were placed on a magnet, and the supernatants were collected.
The supernatants were incubated with antibody-conjugated Dynabeads on
the rotator at 4C for 2 hr. For antibody conjugation, dialyzed antibodies
were coupled to Dynabeads M-270 epoxy beads (Life Technologies,
#14311D) according to the manufacturer’s instructions. After 2-hr incubation,
the samples were placed on the magnet and washed three times with lysis
buffer.
In the case of denaturing conditions, the assay was performed as described
previously (Pan et al., 2016). Briefly, 10% of samples were kept as ‘‘input’’
samples. The rest of the samples were mixed with an equal volume of 6M gua-
nidine buffer (6M guanidine-HCl, 100 mM sodium phosphate, 600 mM NaCl,
30 mM imidazole, and 0.05% Tween 20 [pH 8.0]). The mixed samples were
pre-cleared for 1 hr on an end-over-end rotator with 10 mg of Dynabeads
M-270 epoxy at 4C. The samples were placed on a magnetic stand, and
the supernatants were collected. The supernatants were incubated with
HisPur nickel-nitrilotriacetic acid (Ni-NTA) magnetic beads (Thermo Scientific,
#88831) on the rotator for 2 hr at 4C. The samples were placed on a magnetic
stand and washed twice with 8M urea buffer (8 M urea, 100 mM sodium phos-
phate, 10 mM Tris-Base, and 50 mM imidazole [pH 8.0]). After all urea buffer
was completely removed, the samples containing beads were incubated
with elution buffer (250 mM imidazole, 100 mM sodium phosphate, and
600mMNaCl) for 30min on a rotator. The samples weremixed with b-mercap-
toethanol-containing sample buffer and boiled at 95C for 5 min. The western
blot analysis was performed as described previously (Weihl et al., 2006).
In Vitro Ubiquitination Assay
Recombinant E2 enzyme (UbcH5a/UBE2D1, #E2-616) and the ubiquitylation
kit containing E1 enzyme (#K-995) were purchased from Boston Biochem.
The recombinant fragment of histidine-tagged human p62 (#p62-29505TH)
containing amino acids 83-440 was purchased fromBiomart. Cells were trans-
fected with Cul3 WT-FLAG or Cul3-DN-FLAG. 24 hr later, cells were harvested
in RIPA buffer and immunoprecipitated with FLAG antibody-conjugated Dyna-
beads for 2 hr at 4C. The samples were washed three times with lysis buffer
and incubated with E1, E2, ubiquitin, and His-p62 (500 ng) at 37C for 1 hr. The
samples were mixed with b-mercaptoethanol-containing sample buffer and
boiled at 95C for 5 min.
Fractionation Assay
p62/ MEFs were grown in 10-cm dishes at 80% confluency. After three
washes with ice-chilled PBS, cells were harvested in RIPA buffer with PIC,
PMSF, and NEM. The cells were sonicated twice for 10 s at 4C. 10% of the
sample was taken from the lysate as a ‘‘total’’ fraction. The remaining sample
was centrifuged at 100,000 3 g for 30 min at 4C. After centrifugation, the
supernatant was transferred to a new tube and labeled as a ‘‘supernatant’’
fraction. The rest of sample was resuspended in 200 mL of 7 M urea buffer
(7 M urea, 2 M thiourea, 4% (3-((3-cholamidopropyl) dimethylammonio)-1-pro-
panesulfonate) (CHAPS), and 30 mM Tris [pH 8.5]) and re-sonicated for twice
for 10 s at 4C. The samples were re-centrifuged at 100,000 3 g for 30 min at
4C. The supernatant was transferred to a new tube and labeled as a ‘‘pellet’’
fraction, and the debris was discarded.
Cell Viability Assay
p62/ MEFs grown at 80% confluency were co-transfected with HttQ72-
CFP and HA-p62. 24 hr after the transfection, cells were washed three times
Figure 6. Keap1/Cul3-Mediated Ubiquitination of p62 Facilitates Its Role in Autophagy
(A) Anti-HA and anti-LC3 immunoblots of HA-immunoprecipitated lysates from p62/ MEFs expressing HA-p62-WT or HA-p62-K420R and FLAG-Ub.
(B) Anti-HA and anti-LC3 immunoblots of HA-immunoprecipitated lysates from p62/MEFs expressing HA-p62-WT and FLAG-Ubwith and without Myc-Keap1
and V5-Cul3.
(C) Graph of the Pearson’s coefficient of co-localization of mCherry:GFP fluorescence in p62/ MEFs expressing a dual fluorescent reporter, mCherry-GFP,
fused to p62-WT, p62-K420R, or p62-T350A with or without myc-Keap1 and V5-Cul3. Some cells were also treated with BafA. Representative data were pooled
from three independent experiments.
(D) Quantitation of the percentage of mCherry-p62 bodies that co-localize with GFP-LC3 in p62/ MEFs expressing mCherry-fused p62-WT, p62-K420R or
p62-T350A with or without Myc-Keap1 and V5-Cul3. Representative data were pooled from three independent experiments.
(E) Anti-p62 immunoblot of lysates from control or Keap1/ MEFs treated with cycloheximide for the indicated times. Some cells were also transfected with
Myc-Keap1 and V5-Cul3. The percentage of remaining p62 was quantified from three independent experiments and is represented graphically.
(F) Quantitation of the percent of HttQ72-CFP-positive p62/ MEFs expressing HA-p62-WT, HA-p62-K420R, HA-p62-DUBA, or T350A or co-expressing
myc-Keap1 and V5-cul3. All data are represented as mean ± SEM. *p < 0.05. Anti-GAPDH serves as loading control for blots. Representative data were pooled
from three independent experiments.
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with PBS. The assay was performed according to the instructions of the manu-
facturer (Life Technologies, #L-3224).
Immunocytochemistry and Fluorescence Microscopy
Cells were grown on glass coverslips prior to transfection with plasmid con-
structs. 24 hr after the transfection, cells were washed three times with
PBS, fixed in 4% paraformaldehyde (PFA) for 10 min, and permeabilized
with 0.1% Triton X-100 in PBS for 10 min. After washing three times with
PBS, cells were blocked with 2% BSA in PBS for 30 min to 1 hr at room
temperature (RT). Cells were stained with primary antibody at 4C over-
night, followed by three washes with PBS. Cells were incubated with Alexa
Fluor 555- or 488-conjugated secondary antibody at RT for 1 hr and
mounted with Mowiol medium containing DAPI. 10 random fields were
taken with a 203 objective in a Nikon Eclipse 80i fluorescence microscope.
Co-transfected cells were counted as the total number of cells, and cells
containing ubiquitin-positive aggregates were counted using ImageJ soft-
ware (NIH). The images are presented in pseudo-color. For the Cherry-
eGFP-p62 assay, p62/ MEFs were transfected with Cherry-eGFP-p62-
WT, K420R, or T350A with or without Myc-Keap1/V5-Cul3 for 24 hr. Cells
were washed twice with PBS and mounted with Mowiol medium containing
DAPI without fixation to avoid pH disruption (Goode et al., 2016a). Pear-
son’s coefficient between the red and green channel was measured by
ImageJ.
FRAP
p62/ MEFs were grown on 1.5 glass-bottom 35-mm dishes (MatTek,
#P35G-1.5-10-C) and transfected with pDest-mCherry-p62 for 24 hr prior
to imaging. Immediately before imaging, the medium was replaced with
phenol red-free medium (Gibco, #21063029) containing 10% fetal bovine
serum (FBS), 50 mg/mL penicillin-streptomycin (P/S), 1% sodium pyruvate,
and 1% non-essential amino acids. The live cell samples were placed on a
heated chamber at 37C with 5% CO2. Imaging and photobleaching were
performed with a 403 oil objective using a Nikon A1Rsi confocal micro-
scope. Before bleaching, images of pre-bleached p62 bodies were taken.
A 561-nm laser was used to photobleach p62 bodies for 500 ms. Immedi-
ately after the bleaching, the images were collected every 2 s for a total of
5 min as a post-bleach sample. The fluorescence intensities of post-
bleached p62 bodies were individually measured. In the meantime, the
fluorescence intensities of non-bleached p62 bodies were measured as a
control. An average of p62 bodies in different cells (n R 7 cells containing
p62 bodies) was calculated. The relative florescence intensities were
calculated as the average fluorescence intensities of photobleached
p62 bodies divided by the average fluorescence intensities of pre-bleached
samples.
Cycloheximide Assay
Keap1/ or control MEFs were transfected at 80% confluency with empty
vector or Myc-Keap1/V5-Cul3. 24 hr after transfection, cells were treated
with 10 mg/mL cycloheximide for varying times.
Statistical Analysis
A two-tailed Student’s t test was performed. For all tests, p < 0.05 was consid-
ered statistically significant. Data are represented as mean ± SEM.
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